Search results
Showing 16 to 30 of 71 results for parkinson
Recommendation ID NG71/1 Question Combination treatment for Parkinson's disease dementia:- What is the effectiveness of combination...
Suspected neurological conditions: recognition and referral (NG127)
This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.
Show all sections
Physiotherapy:- Does physiotherapy started early in the course of Parkinson's disease, as opposed to after motor symptom onset, confer...
Question Orthostatic hypotension treatment:- For people with Parkinson's disease, what is the most effective pharmacological treatment...
MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease, which could include randomised...
for rapid eye movement sleep behaviour disorder (RBD) in people with Parkinson's disease? Any explanatory notes(if applicable) Why this...
Extradural motor cortex stimulation (EMCS) for Parkinson's disease
Register an interest in this interventional procedure ...
MRI guided focused ultrasound subthalamotomy in parkinson's disease
Awaiting development [GID-IPG10402] Expected publication date: 12 December 2024
NICE has developed a medtech innovation briefing (MIB) on the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation
A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.
Istradefylline with levodopa for treating motor fluctuations in Parkinson's disease [ID3868]
Awaiting development [GID-TA10773] Expected publication date: TBC
(2020) to estimate quality-adjusted life years (QALYs) from the Unified Parkinson's Disease Rating Scale (UPDRS) domain scores. The...
This quality standard covers the prevention, diagnosis and management of delirium in adults (aged 18 and over) in hospital or long-term care settings (such as residential care or nursing homes). It describes high-quality care in priority areas for improvement.
View quality statements for QS63Show all sections
Sections for QS63
- Quality statements
- Quality statement 1: Assessing recent changes that may indicate delirium
- Quality statement 2: Interventions to prevent delirium
- Quality statement 3: Use of antipsychotic medication for people who are distressed
- Quality statement 4: Information and support
- Quality statement 5: Communication of diagnosis to GPs
- Update information
- About this quality standard
Delirium: prevention, diagnosis and management in hospital and long-term care (CG103)
This guideline covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications.
Urinary incontinence in neurological disease: assessment and management (CG148)
This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.